GENSCRIPT BIOTECH CORPORATION Pricing & Demo

Are you from this Company?
GENSCRIPT BIOTECH CORPORATION
Write a Review
New Jersey, USA
2002
$101MN to $500MN
Enterprise
43 Likes
80 Buyers Negotiating
Summary
No Summary And Details

Popular Comparisons

Discussions

Strengths
  • +14
    Chemically competent cells
  • +8
    High (>1 x 10^9 cfu/µg)
  • +11
    High Throughput (10^8-10^9 cfu/µg)
  • +9
    Medium (10^8-10^9 cfu/µg)
  • +10
    Sub Cloning (10^6-10^7 cfu/µg)
  • +7
    Application - Cloning
  • +9
    Application - High Through put cloning
  • +14
    Application - Large Plasmid (BAC- Bacterial Artificial Chromosomes)
  • +8
    Application - Phage display/Library Production
  • +12
    Application - Protein Expression
  • +11
    Application - Sub cloning & Routine
  • +13
    Cloning
  • +14
    Phage display/Library Production
  • +5
    R&D spend in FY2016
  • +6
    Breadth and Depth of Product Offerings
  • +13
    Other Applications
  • +7
    Product Features and Functionality
  • +14
    Products in pipeline
  • +5
    Electrocompetent cells
  • +5
    Application - Mutagenesis
Cautions
  • -6
    Application - Single Stranded DNA Production
  • -10
    Application - Toxic/unstable DNA cloning
  • -8
    Focus on Product Innovation
  • -5
    High Through put cloning
  • -10
    Large Plasmid (BAC- Bacterial Artificial Chromosomes)
  • -13
    Lentiviral Vectors
  • -11
    Mutagenesis
  • -9
    Other Application
  • -8
    Protein Expression
  • -12
    Single Stranded DNA Production
  • -7
    Sub cloning & Routine
  • -6
    Toxic/unstable DNA cloning
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup
logo-360
  • saved

    You haven’t saved anything yet

    To save, search for Vendors by
    Name or Category, then tap the heart